Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recruiting × Hyperprolactinemia × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 108 Carcinoma, Non-Small-Cell Lung 86 Prostatic Neoplasms 54 Colorectal Neoplasms 46 Nasopharyngeal Carcinoma 43 Neoplasms 39 Stomach Neoplasms 31 Multiple Myeloma 31 Lung Neoplasms 27 Neoplasm Metastasis 24 Leukemia, Myeloid, Acute 24 Carcinoma, Hepatocellular 24 Recurrence 22 Ovarian Neoplasms 22 Rectal Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Uterine Cervical Neoplasms 19 Triple Negative Breast Neoplasms 19 Pancreatic Neoplasms 19 Esophageal Neoplasms 19 Brain Neoplasms 19 Colonic Neoplasms 18 Small Cell Lung Carcinoma 17 Urinary Bladder Neoplasms 15 Myasthenia Gravis 14 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma, Follicular 14 Esophageal Squamous Cell Carcinoma 13 Endometrial Neoplasms 13 Leukemia, Lymphocytic, Chronic, B-Cell 12

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡